NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹995 Cr | ₹752 Cr | ₹465 Cr | ₹308 Cr | ₹248 Cr |
What is the latest Profit & Loss Account Balance ratio of NEULAND LABORATORIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹995 Cr |
| Mar2024 | ₹752 Cr |
| Mar2023 | ₹465 Cr |
| Mar2022 | ₹308 Cr |
| Mar2021 | ₹248 Cr |
How is Profit & Loss Account Balance of NEULAND LABORATORIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹995 Cr | 32.18 | |
| Mar2024 | ₹752 Cr | 61.74 | |
| Mar2023 | ₹465 Cr | 50.99 | |
| Mar2022 | ₹308 Cr | 24.17 | |
| Mar2021 | ₹248 Cr | - | |
Compare Profit & Loss Account Balance of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,984.8 Cr | 3.2% | 13.7% | 57.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 3.2% |
13.7% |
57.3% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses